VNA
KBIO

Valley National Advisers’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Valley National Advisers’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-20
Closed – – 699
2015
Q4 		$0 Hold
20
– – ﹤0.01% 696
2015
Q3 		$0 Hold
20
– – ﹤0.01% 690
2015
Q2 		$0 Hold
20
– – ﹤0.01% 676
2015
Q1 		$0 Buy
+20
New +$90 ﹤0.01% 654

Other funds holding KBIO

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Valley National Advisers's KBIO Position: Q1 2016 in Review

Valley National Advisers sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2016, closing a stake of 20 shares.

Valley National Advisers first reported a position in KBIO in Q1 2015 and held it in 4 quarters. The position peaked at $0 in Q4 2015. 1 fund tracked by Wall St. Rank holds KBIO as of Q1 2016.

  • Valley National Advisers reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2016 after selling out during the quarter.
  • Valley National Advisers sold 20 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2016.
  • Valley National Advisers first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q1 2015 and held it in 4 quarters.
  • Valley National Advisers's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $0 in Q4 2015.
  • 1 fund tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2016.

Based on Valley National Advisers's 13F filing for Q1 2016, filed 21 Apr 2016.